Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
UBS
Covington
Queensland Health
Teva
Fish and Richardson
Daiichi Sankyo
Harvard Business School
Citi

Generated: January 22, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: delafloxacin meglumine

« Back to Dashboard

delafloxacin meglumine

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Melinta BAXDELA delafloxacin meglumine POWDER;INTRAVENOUS 208611 NDA Melinta Therapeutics, Inc 70842-102-03 1 VIAL, GLASS in 1 CARTON (70842-102-03) > 10.5 mL in 1 VIAL, GLASS
Melinta BAXDELA delafloxacin meglumine TABLET;ORAL 208610 NDA Melinta Therapeutics, Inc 70842-101-01 1 BOTTLE in 1 CARTON (70842-101-01) > 20 TABLET in 1 BOTTLE
Melinta BAXDELA delafloxacin meglumine TABLET;ORAL 208610 NDA Melinta Therapeutics, Inc 70842-101-02 2 BLISTER PACK in 1 CARTON (70842-101-02) > 10 TABLET in 1 BLISTER PACK
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Daiichi Sankyo
Baxter
Citi
Colorcon
Merck
McKesson
Deloitte
Healthtrust